Original Research

Published on 22 Oct 2021

Ultrasound-Targeted Microbubble Destruction Alleviates Immunosuppression Induced by CD71+ Erythroid Progenitor Cells and Promotes PDL-1 Blockade Immunotherapy in the Lewis Lung Cancer Model

in Cancer Molecular Targets and Therapeutics

Xi Tan
Cuo Yi
Yi Zhang
Najiao Tang
Yali Xu
Zheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.768222

8,271 views
8 citations

Systematic Review

Published on 22 Oct 2021

E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications

in Cancer Molecular Targets and Therapeutics

Yingshuang Wang
Jiawen Dai
Youqin Zeng
Jinlin Guo
Jie Lan

Frontiers in Oncology

doi 10.3389/fonc.2021.752604

5,116 views
9 citations

Original Research

Published on 22 Oct 2021

New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells

in Cancer Molecular Targets and Therapeutics

Cyndia Charfi
Michel Demeule
Jean-Christophe Currie
Alain Larocque
Alain Zgheib
Bogdan Alexandru Danalache
Amira Ouanouki
Richard Béliveau
Christian Marsolais
Borhane Annabi

Frontiers in Oncology

doi 10.3389/fonc.2021.760787

7,598 views
17 citations

Systematic Review

Published on 21 Oct 2021

The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis

in Cancer Molecular Targets and Therapeutics

Guang Zhu
Ying Liu
Lei Zhao
Zhenhua Lin
Yingshi Piao

Frontiers in Oncology

doi 10.3389/fonc.2021.622331

2,729 views
6 citations

Original Research

Published on 20 Oct 2021

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib

in Cancer Molecular Targets and Therapeutics

Fabio Scirocchi
Chiara Napoletano
Angelica Pace
Hassan Rahimi Koshkaki
Alessandra Di Filippo
Ilaria Grazia Zizzari
Marianna Nuti
Aurelia Rughetti

Frontiers in Oncology

doi 10.3389/fonc.2021.755433

5,965 views
23 citations

Review

Published on 20 Oct 2021

TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis

in Cancer Molecular Targets and Therapeutics

Jiahao Huang
Yini Wang
Jinlong Liu
Ming Chu
Yuedan Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.742462

3,095 views
3 citations

Original Research

Published on 19 Oct 2021

Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients

in Cancer Molecular Targets and Therapeutics

Wenwen Zhang
Bingyang Hu
Jun Han
Zhanbo Wang
Guangyu Ma
Huiyi Ye
Jing Yuan
Junning Cao
Ze Zhang
Jihang Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.747950

4,547 views
64 citations

Original Research

Published on 19 Oct 2021

Novel Natural Inhibitors Targeting Enhancer of Zeste Homolog 2: A Comprehensive Structural Biology Research

in Cancer Molecular Targets and Therapeutics

Weihang Li
Ziyi Ding
Yunlong Zhao
Min Jiang
Shilei Zhang
Hongzhe Zhao
Ke Lei
Rui Xu
Yingjing Zhao
Dong Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.741403

3,454 views
5 citations

Original Research

Published on 15 Oct 2021

Identification of a Putative Enhancer RNA for EGFR in Hyper-Accessible Regions in Esophageal Squamous Cell Carcinoma Cells by Analysis of Chromatin Accessibility Landscapes

in Cancer Molecular Targets and Therapeutics

Sangyong Choi
Adwait Sathe
Ewy Mathé
Chao Xing
Zui Pan

Frontiers in Oncology

doi 10.3389/fonc.2021.724687

3,857 views
4 citations

Review

Published on 14 Oct 2021

Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention

in Cancer Molecular Targets and Therapeutics

Yangyang Feng
Tongyue Zhang
Yijun Wang
Meng Xie
Xiaoyu Ji
Xiangyuan Luo
Wenjie Huang
Limin Xia

Frontiers in Oncology

doi 10.3389/fonc.2021.770428

10,616 views
56 citations

Systematic Review

Published on 14 Oct 2021

The Value of Circulating Circular RNA in Cancer Diagnosis, Monitoring, Prognosis, and Guiding Treatment

in Cancer Molecular Targets and Therapeutics

Yunjing Zhang
Ying Wang
Xinwan Su
Ping Wang
Weiqiang Lin

Frontiers in Oncology

doi 10.3389/fonc.2021.736546

5,163 views
20 citations

Review

Published on 14 Oct 2021

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value

in Cancer Molecular Targets and Therapeutics

Xupeng Chai
Eloy Yinwang
Zenan Wang
Zhan Wang
Yucheng Xue
Binghao Li
Hao Zhou
Wenkan Zhang
Shengdong Wang
Yongxing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.692788

12,385 views
23 citations

Original Research

Published on 14 Oct 2021

CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma

in Cancer Molecular Targets and Therapeutics

Jiancheng Lv
Zijian Zhou
Jingzi Wang
Xiao Yang
Hao Yu
Jie Han
Dexiang Feng
Baorui Yuan
Qikai Wu
Pengchao Li

Frontiers in Oncology

doi 10.3389/fonc.2021.659166

2,512 views
5 citations

Original Research

Published on 13 Oct 2021

Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation

in Cancer Molecular Targets and Therapeutics

Tina Jost
Lucie Heinzerling
Rainer Fietkau
Markus Hecht
Luitpold V. Distel

Frontiers in Oncology

doi 10.3389/fonc.2021.740002

9,236 views
42 citations

Original Research

Published on 13 Oct 2021

Chemical Synthesis of the PAX Protein Inhibitor EG1 and Its Ability to Slow the Growth of Human Colorectal Carcinoma Cells

in Cancer Molecular Targets and Therapeutics

Lorissa McDougall
Jui Thiang Brian Kueh
Jake Ward
Joel D. A. Tyndall
Adele G. Woolley
Sunali Mehta
Cherie Stayner
David S. Larsen
Michael R. Eccles

Frontiers in Oncology

doi 10.3389/fonc.2021.709540

2,507 views

Review

Published on 11 Oct 2021

Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials

in Cancer Molecular Targets and Therapeutics

Lisha Mou
Xiaohe Tian
Bo Zhou
Yongqiang Zhan
Jiao Chen
Ying Lu
Jing Deng
Ying Deng
Zijing Wu
Qi Li

Frontiers in Oncology

doi 10.3389/fonc.2021.752725

9,676 views
42 citations

Navigation group

Articles

Ultrasound-Targeted Microbubble Destruction Alleviates Immunosuppression Induced by CD71+ Erythroid Progenitor Cells and Promotes PDL-1 Blockade Immunotherapy in the Lewis Lung Cancer Model

E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications

New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells

The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib

TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis

Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients

Novel Natural Inhibitors Targeting Enhancer of Zeste Homolog 2: A Comprehensive Structural Biology Research

Identification of a Putative Enhancer RNA for EGFR in Hyper-Accessible Regions in Esophageal Squamous Cell Carcinoma Cells by Analysis of Chromatin Accessibility Landscapes

Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention

The Value of Circulating Circular RNA in Cancer Diagnosis, Monitoring, Prognosis, and Guiding Treatment

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value

CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma

Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation

Chemical Synthesis of the PAX Protein Inhibitor EG1 and Its Ability to Slow the Growth of Human Colorectal Carcinoma Cells

Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials